Prior Auth Required

0049U - NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceNPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative
Procedure / Service Description

Cerebral Perfusion Anaysis, Ct W/Contrst, Postprocess, Determ Cerebral Blood Flow/Vol & - instability, matched with normal specimens, utilizing formalin-fixed paraffin-embedded tumor 0048U tissue, report of clinically significant mutation(s) 0049U NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative Targeted genomic sequence analysis panel, acute myelogenous leukemia, DNA analysis, 194 0050U genes, interrogation for sequence variants, copy number variants or rearrangements

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.